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State-of-the-Art Paper
Strategies to Identify and Treat Resistant Hypertension
This state-of-the-art paper focuses on resistant hypertension, which Sarafidis andBakris define as failure to achieve goal blood pressure (BP) with maximum
tolerated dose of at least 3 antihypertensive drugs including a diuretic. The prevalence
of resistant hypertension is increasing due to aging, obesity, sleep apnea, and kidney
disease.Managementmust begin with patient evaluation to confirm the diagnosis and
exclude “pseudo-resistance.” BP control is achievable if the treatment regimen focuses
on the etiology of hypertension and logical combinations of medications. See page
1749. See figure.
Interventional Cardiology
Bivalirudin May Reduce Costs in ACS Patients
The ACUITY trial randomized acute coronary syndrome (ACS) patients with aplanned early invasive strategy to either bivalirudin with or without glycoprotein
IIb/IIIa inhibition (GPI) or heparin with routine GPI. There were no differences in
ischemic outcomes, but there was reduced bleeding in the bivalirudin arms. This
economic analysis of the trial shows that during the initial hospitalization, use of
bivalirudin monotherapy resulted in net savings of $600/patient compared with
heparin  routine upstream GPI and $200/patient compared with heparin 
catheterization laboratory GPI. These cost savings were obtained despite higher costs
for antithrombotic therapy and were driven by reductions in bleeding complications
and earlier hospital discharge.This analysis suggests that bivalirudinmonotherapy is an
economically attractive alternative to heparin-based regimens in ACS patients. See
page 1758.
Page 1775
Preventive Cardiology
Meta-Analysis Shows Mortality Benefit for Primary Prevention With Statins
The use of statins for primary prevention of cardiovascular mortality and events isstill questioned. Mills and colleagues conducted a meta-analysis of 19 random-
ized trials with over 60,000 subjects and at least 1 year of follow-up. The relative risk
(RR) for all-cause mortality was 0.93, and for cardiovascular deaths was 0.89. The RR
formyocardial infarctions was 0.77. There was no evidence of increased risk for cancer
or rhabdomylosis. This meta-analysis confirms that statins can reduce the risk of death
in primary prevention patients. See page 1769. See figure.
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Rhythm Disorders
in Heart Failure
Altered Calcium Cycling Associated With T-Wave Alternans, Risk of VT
Narayan and colleagues hypothesized that abnormalities of calcium cyclingmightexplain ventricular action potential (AP) oscillations. Fifty-three subjects with
reduced left ventricular (LV) function and 18 control patients underwent a protocol to
identify subtle changes in the AP morphology. AP alternans, slight variations in
beat-to-beat AP morphology, had higher magnitude in subjects with LV dysfunction.
AP alternans predicted ventricular tachycardia (VT)/ventricular fibrillation (VF) dur-
ing follow-up. Some patients with systolic dysfunction have ventricular AP alternans
that predicts the risk of VT/VF and appears to be caused by altered calcium cycling.
See page 1782. See figure.
Page 1797
Cardiac Effects of Diabetes
Myocardial Steatosis Linked to Diabetes and Diastolic Dysfunction
Recent evidence suggests that increased myocardial fatty acid uptake may be thecause of diabetic nonischemic cardiomyopathy. Rijzewijk and colleagues report
that myocardial triglyceride content is significantly higher in diabetic patients com-
pared with healthy volunteers. Indexes of diastolic function, including left ventricular
E/A ratio and E peak deceleration, were also impaired in diabetic patients. Impaired
diastolic filling correlated with myocardial triglyceride content, independently of age,
body mass index, heart rate, visceral fat, and diastolic blood pressure. Myocardial
triglyceride content is increased in diabetic patients and may be the link between
diabetes and impaired left ventricular diastolic function. See pages 1793 and
1800. See figure.(continued on page A-36)
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Pre-Clinical Research
Calcium Dependent NOX5 NADPH Oxidase Active in Atherosclerotic Lesions
The NOX-based nicotinamide adenine dinucleotide phosphate (NADPH) oxi-dases aremajor sources of reactive oxygen species (ROS) inhumanvessels, but the
location and activity of the recently describedNOX5 is lesswell understood.Guzik and
colleagues analyzed segments of human coronary arteries harvested from explanted
hearts of patients with either coronary artery disease (CAD) or nonischemic cardiomy-
opathies. There was a marked increase in NOX5 protein and messenger ribonucleic
acid in patientswithCAD.NOX5-dependent productionofROSwas 7-fold higher in
patients with CAD. This article identifies NOX5 as a calcium-dependent source of
ROS in atherosclerosis. See pages 1803 and 1810. See figure.
